Authors: BRODSKY I BIGGS JC SZER J CRILLEY P ATKINSON K DOWNS K DODDS A CONCANNON AJ AVALOS BR TUTSCHKA P KAPOOR N TOPOLSKY D BULOVA SI COPELAN EA

Citation: I. Brodsky et al., TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA WITH ALLOGENEIC BONE-MARROWTRANSPLANTATION AFTER PREPARATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE (BUCY2) - AN UPDATE, Seminars in oncology, 20(4), 1993, pp. 27-31

Authors: CRILLEY P LAZARUS H TOPOLSKY D CIOBANU N CREGER RJ FOX RM BULOVA SI SHINA DC GUCALP R COOPER BW SOEGIARSO W STYLER M BRODSKY I

Citation: P. Crilley et al., COMPARISON OF PREPARATIVE TRANSPLANTATION REGIMENS USING CARMUSTINE ETOPOSIDE CISPLATIN OR BUSULFAN ETOPOSIDE CYCLOPHOSPHAMIDE IN LYMPHOID MALIGNANCIES, Seminars in oncology, 20(4), 1993, pp. 50-54

Authors: ABOUNA GM KUMAR MSA STEPHAN R PRIOR JE LYONS P BULOVA SI ALABDULLAH IH

Citation: Gm. Abouna et al., INDUCTION THERAPY WITH ANTITHYMOCYTE GLOBULIN REDUCES THE INCIDENCE OF ALLOGRAFT-REJECTION AND IMPROVES GRAFT-SURVIVAL IN CADAVER RENAL-TRANSPLANTATION, Transplantation proceedings, 25(3), 1993, pp. 2241-2242